GLP-1 drugs copy a hormone your gut releases after you eat, glucagon-like peptide-1 (a signal that curbs appetite and helps control blood sugar). The approved medicines in this class treat type 2 diabetes and obesity, plus a short list of related conditions, and in the United States all of them are prescription-only.
The science is the easy part. Money is the hard part. Branded list prices sit high, cash programs and telehealth clinics price the same molecules very differently, and many plans cover the diabetes use while excluding the weight one. US list prices for branded GLP-1 medicines run above $1,000 for a month of treatment before rebates (National Academy of Medicine), which is why two people on the identical drug can pay amounts that are nowhere near each other.
What GLP-1 drugs actually do in the body
A GLP-1 receptor agonist (a drug that switches on the GLP-1 receptor) does four things at once. It prompts the pancreas to release insulin when blood sugar is high. It lowers glucagon, the hormone that pushes sugar up. It slows how fast the stomach empties. And it acts on appetite centres in the brain, so meals end sooner and food thoughts quiet down.
That combination explains both the benefit and the nuisance. Lower A1c and steady weight loss come from the same mechanism that causes nausea, fullness and constipation. Tirzepatide adds a second target, GIP, which is why it is often described as a dual agonist rather than a plain GLP-1.
The class also has outcome data beyond glucose and weight. a BMJ review and meta-analysis found GLP-1 receptor agonist drugs reduced the risk of major heart-related events (University of Chicago Medicine). Several labels now reflect heart and kidney findings, not just blood sugar, and that matters for coverage because the diagnosis on the prescription often decides who pays.
The GLP-1 drugs list, and yes, Ozempic is one
There are fewer molecules than brand names, which is the main source of confusion. Ozempic and Wegovy are the same active drug at different approved uses and dose ranges. Mounjaro and Zepbound are the same relationship for tirzepatide.
Same Molecule, Different Brand Names
| Diabetes Brand | Weight Management Brand | |
|---|---|---|
| Semaglutide | Ozempic | Wegovy |
| Tirzepatide | Mounjaro | Zepbound |
| Molecule | Brand names | Form and schedule | Main approved uses in the US |
|---|---|---|---|
| Semaglutide | Ozempic, Wegovy, Rybelsus | Weekly injection; Rybelsus is a daily tablet | Type 2 diabetes; chronic weight management under Wegovy; added heart and kidney indications on some labels |
| Tirzepatide | Mounjaro, Zepbound | Weekly injection | Type 2 diabetes; chronic weight management and obstructive sleep apnea in adults with obesity under Zepbound |
| Dulaglutide | Trulicity | Weekly injection | Type 2 diabetes, with cardiovascular risk reduction on the label |
| Liraglutide | Victoza, Saxenda | Daily injection | Type 2 diabetes; weight management under Saxenda |
| Exenatide | Byetta | Twice-daily injection | Type 2 diabetes |
People searching for GLP-1 pills usually want an oral option. Rybelsus is the tablet in this class, and it is approved for type 2 diabetes rather than weight loss. Compounded semaglutide or tirzepatide sold as drops, capsules or cheap vials is not an FDA-approved product, and it is not reviewed for safety, strength or quality the way the branded pens are.
Which GLP-1 is strongest for weight loss
On average weight loss, tirzepatide sits at the top of the class. In the pivotal trial programmes, semaglutide averaged roughly 15% of body weight lost and tirzepatide roughly 20% at the higher doses studied (peer-reviewed review in PMC). Older agents such as liraglutide produce smaller average losses.
Averages are not your result. Trial participants had structured diet and activity support, and the spread around those averages is wide. Some people lose more than the average and some lose very little.
Strongest is also not the same as best. The drug that fits is usually the one your plan will cover, at a dose you can tolerate, on a schedule you will keep, with a label that matches your other conditions. If you have sleep apnea, established heart disease or chronic kidney disease alongside excess weight, the specific label wording can change both the clinical logic and the paperwork.
What GLP-1 drugs cost per month
Cash prices in this category move around more than almost any other class, because you are paying for three separate things: the medicine, the clinician who prescribes and monitors it, and any membership or platform fee stacked on top. Here is the tracked range for semaglutide across the providers in our dataset.
$99 to $499
No provider matches that filter. .
See every provider we track, with filters and sorting
When you read a monthly figure, work out what it includes before you compare it with anything else:
- The medication itself, and whether the price holds at higher maintenance doses
- Clinician visits, dose changes and messaging between visits
- A separate membership or subscription fee, billed monthly or up front
- Lab work, if the clinic requires baseline bloods
- Shipping and cold handling, or a pharmacy pickup you arrange yourself
- Whether the quoted price is a first-month promotional rate or the steady-state rate
Because dose escalation usually raises the price, the number that matters is the annual one, not the introductory one. Run your own figure before you commit.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
How insurance decides what you actually pay
Two people with the same prescription and the same employer can pay wildly different amounts, and the reasons are mechanical rather than mysterious. These are the levers that set your price:
- Formulary placement. Many plans cover a GLP-1 for type 2 diabetes and exclude the same molecule when the indication is weight management.
- Prior authorization. The clinician must document a diagnosis, a BMI threshold, related conditions, and often past attempts at diet and lifestyle change.
- Step therapy. The plan may require a cheaper drug first, and a documented failure or intolerance, before it approves the one you were prescribed.
- Deductible phase. Before the deductible is met, you may be paying close to the negotiated price, not a copay.
- Copay versus coinsurance. A flat copay is predictable. Coinsurance of 25% or 30% on a high-cost drug is not.
- Quantity limits and reauthorization. Approvals often run for a set period and require documented weight or A1c progress to renew.
Medicare Part D excludes drugs used only for weight loss, so coverage generally turns on whether the prescription is written for type 2 diabetes or another covered indication. Medicaid coverage of weight-management use varies by state. Employer plans increasingly carve out the weight indication entirely, sometimes mid-year.
If you have coverage, the cash route is not automatically worse or better. Compare them side by side rather than assuming.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
No provider matches that filter. .
See every provider we track, with filters and sorting
How to get a GLP-1 prescription, online or in person
There is no legitimate way to get one of these medicines without a licensed clinician. Peptides sold as research chemicals, or vials shipped without any clinical review, sit outside the regulated supply chain, and nobody is checking what is in them. A telehealth or telemedicine visit is still a clinical visit; it is remote, not unsupervised.
- Collect your numbers first: current weight and height, weight history, A1c or fasting glucose if you have one, blood pressure, and a list of medicines and past surgeries.
- Decide between your own primary care or endocrinology clinic and a telemedicine service. Primary care is better placed to bill insurance; online clinics tend to move faster on cash pricing.
- Complete the review. Expect questions about thyroid cancer in the family, pancreatitis, gallbladder disease, kidney function, pregnancy plans and eating disorder history.
- Have labs drawn if requested. A1c and kidney function are the common baseline pair.
- Route the prescription. With coverage, expect a prior authorization step. Without it, confirm the price at your maintenance dose, not just the starting dose.
Membership fees are the detail most people miss. A low medication price attached to a mandatory subscription can cost more over a year than a higher all-in price with no fee.
Best on value
What you get for what you pay.
- Found8.9 / 10
- LillyDirect8.5 / 10
- ShedRx8.2 / 10
- Henry Meds8.2 / 10
- Lumimeds8 / 10
Lowest monthly price
Cheapest verified plan for a new self-pay patient.
- Amazon One Medical$17/mo
- LifeMD$19/mo
- PlushCare$20/mo
- Hims$22/mo
- Strut Health$25/mo
Ranked from our own scores, recomputed as data changes. Providers cannot pay for a place.
Doses go up slowly, and that is deliberate
Every drug in this class starts below its effective dose. The first weeks are about tolerance, not results. Doses then step up at set intervals, commonly around four weeks apart, until you reach a maintenance dose that balances effect against side effects. Semaglutide and tirzepatide have different ladders, and the weight-management brands go higher than the diabetes brands.
Two practical points. First, dosage charts copied from forums do not account for your kidney function, your other medicines or how you handled the last step, so the schedule should come from your prescriber. Second, pens are marked in specific increments, and drawing from a vial with a syringe is where dosing errors happen. If you are ever unsure how much you are about to inject, stop and ask a pharmacist before you dose.
Quick tip: write your dose, date and injection site in your phone each week, so a missed or doubled dose is obvious.
Side effects, from common to serious
Most side effects are digestive, appear after a dose increase, and settle over days to weeks. The common ones include:
- Nausea, vomiting and burping
- Diarrhea or constipation
- Reduced appetite and early fullness
- Abdominal pain, reflux and fatigue
- Injection site reactions
- Headache and dizziness, often linked to eating and drinking too little
The ones that need prompt medical attention are less common but matter more:
- Severe, persistent abdominal pain radiating to the back, which can signal pancreatitis
- Right upper abdominal pain, fever or yellowing skin, which can signal gallbladder disease
- Repeated vomiting with reduced urine output, which risks dehydration and kidney injury
- Low blood sugar, mainly when a GLP-1 is combined with insulin or a sulfonylurea
- Rapid vision changes, particularly in people with existing diabetic retinopathy
- Swelling of the face or throat, or trouble breathing, which suggests a serious allergic reaction
On the cancer question: semaglutide, tirzepatide, liraglutide and dulaglutide carry a boxed warning about thyroid C-cell tumours seen in rodents, and human relevance has not been established, per the FDA-approved labelling. Long-term human data continue to accumulate, and delayed stomach emptying is now recognised as a factor for anesthesia, so tell any surgical or procedure team you are on one of these drugs.
Monitoring is straightforward: A1c if you have diabetes, weight, blood pressure, kidney function when you have vomiting or existing kidney disease, and a conversation about contraception if pregnancy is possible. Because these drugs slow gastric emptying, they can change how quickly other oral medicines are absorbed, which is worth flagging for anything with a narrow margin.
Who cannot take a GLP-1
These are absolute or near-absolute reasons to avoid the class: a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or a previous serious allergic reaction to the drug. Pregnancy is a stop point, and the weight-management brands are not intended for use while pregnant or trying to conceive.
Other situations call for caution and a real discussion rather than a questionnaire: a history of pancreatitis, gastroparesis or severe reflux, active gallbladder disease, type 1 diabetes, advanced kidney disease, a history of an eating disorder, and any regimen that already includes insulin or a sulfonylurea, where doses often need adjusting to avoid hypoglycemia.
What to expect on the scale, including without diabetes
You do not need diabetes to be a candidate. The weight-management approvals are written around BMI thresholds, usually obesity, or overweight plus a weight-related condition such as high blood pressure, sleep apnea or high cholesterol. That is the mainstream use of GLP-1 drugs for weight loss.
Timing is gradual. Appetite usually changes within the first weeks, while meaningful scale movement builds over months as the dose climbs. Loss tends to slow and plateau as the body adjusts. Protein intake and resistance training matter here, because rapid loss takes muscle as well as fat.
The uncomfortable part: in trial follow-ups, most people regained a large share of the weight after stopping. Treat this as a long-term medication decision with a long-term budget, not a short course. That is exactly why the annual cost figure, not the first-month promotion, should drive your choice among GLP-1 drugs for weight loss.
What to sort out before you start
- Confirm whether your plan covers the molecule for your indication, and get the prior authorization criteria in writing
- Ask what the price is at the maintenance dose, not the starting dose
- Ask whether a membership fee applies and whether it is refundable
- Ask whether the product is an FDA-approved pen or a compounded preparation, and get the answer plainly
- Ask who handles side effects between visits, and how fast they respond
- Ask what happens to your prescription and your price if the plan drops coverage mid-year
Bring your own numbers to that conversation. A clinician can move much faster when weight history, A1c, blood pressure and a current medication list are already in front of them.
Before You Start a GLP-1: What to Confirm
- Does your plan cover this molecule for your specific indication?
- What is the price at the maintenance dose, not just the starting dose?
- Is there a membership or subscription fee, and is it refundable?
- Is the product an FDA-approved pen or a compounded preparation?
- Who handles side effects between visits, and how quickly do they respond?
- What happens to your price if coverage is dropped mid-year?
Authoritative sources
- National Academy of Medicine analysis of GLP-1 cost, safety and access
- Peer-reviewed review of GLP-1 based drug development and obesity outcomes
- BMJ review and meta-analysis summary on GLP-1 receptor agonists
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.
